Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,786
archived clinical trials in
Dermatology

Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis Patients
Status: Enrolling
Updated:  5/19/2016
Clinical Research Facility
mi
from
East Windsor, NJ
Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis Patients
Status: Enrolling
Updated: 5/19/2016
Clinical Research Facility
mi
from
East Windsor, NJ
Click here to add this to my saved trials
Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis Patients
Status: Enrolling
Updated:  5/19/2016
Clinical Research Facility
mi
from
Buffalo, NY
Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis Patients
Status: Enrolling
Updated: 5/19/2016
Clinical Research Facility
mi
from
Buffalo, NY
Click here to add this to my saved trials
Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis Patients
Status: Enrolling
Updated:  5/19/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis Patients
Status: Enrolling
Updated: 5/19/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis Patients
Status: Enrolling
Updated:  5/19/2016
Clinical Research Facility
mi
from
Austin, TX
Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis Patients
Status: Enrolling
Updated: 5/19/2016
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis Patients
Status: Enrolling
Updated:  5/19/2016
Clinical Research Facility
mi
from
College Station, TX
Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis Patients
Status: Enrolling
Updated: 5/19/2016
Clinical Research Facility
mi
from
College Station, TX
Click here to add this to my saved trials
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
Status: Enrolling
Updated:  5/24/2016
Eskenazi Health Outpatient Care Center
mi
from
Indianapolis, IN
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
Status: Enrolling
Updated: 5/24/2016
Eskenazi Health Outpatient Care Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
Status: Enrolling
Updated:  5/24/2016
Eskenazi Health Center-Blackburn
mi
from
Indianapolis, IN
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
Status: Enrolling
Updated: 5/24/2016
Eskenazi Health Center-Blackburn
mi
from
Indianapolis, IN
Click here to add this to my saved trials
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
Status: Enrolling
Updated:  5/24/2016
Eskenazi Health Center- Forest Manor
mi
from
Indianapolis, IN
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
Status: Enrolling
Updated: 5/24/2016
Eskenazi Health Center- Forest Manor
mi
from
Indianapolis, IN
Click here to add this to my saved trials
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
Status: Enrolling
Updated:  5/24/2016
Eskenazi Health West 38th Street
mi
from
Indianapolis, IN
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
Status: Enrolling
Updated: 5/24/2016
Eskenazi Health West 38th Street
mi
from
Indianapolis, IN
Click here to add this to my saved trials
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
Status: Enrolling
Updated:  5/24/2016
Eskenazi Health Center- Pecar
mi
from
Indianapolis, IN
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
Status: Enrolling
Updated: 5/24/2016
Eskenazi Health Center- Pecar
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine
Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine
Status: Enrolling
Updated:  5/24/2016
Eskenazi Health Outpatient Care Center
mi
from
Indianapolis, IN
Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine
Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine
Status: Enrolling
Updated: 5/24/2016
Eskenazi Health Outpatient Care Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine
Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine
Status: Enrolling
Updated:  5/24/2016
Eskenazi Health Center-Blackburn
mi
from
Indianapolis, IN
Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine
Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine
Status: Enrolling
Updated: 5/24/2016
Eskenazi Health Center-Blackburn
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine
Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine
Status: Enrolling
Updated:  5/24/2016
Eskenazi Health Center- Forest Manor
mi
from
Indianapolis, IN
Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine
Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine
Status: Enrolling
Updated: 5/24/2016
Eskenazi Health Center- Forest Manor
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine
Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine
Status: Enrolling
Updated:  5/24/2016
Eskenazi Health West 38th Street
mi
from
Indianapolis, IN
Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine
Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine
Status: Enrolling
Updated: 5/24/2016
Eskenazi Health West 38th Street
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine
Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine
Status: Enrolling
Updated:  5/24/2016
Eskenazi Health Pecar
mi
from
Indianapolis, IN
Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine
Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine
Status: Enrolling
Updated: 5/24/2016
Eskenazi Health Pecar
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study to Evaluate the Effectiveness and Safety of RXI-109 on the Outcome of Keloid Excision Surgery in Healthy Adults
A Multi-Center, Prospective, Randomized, Single-Blind, Within-Subject Controlled, Phase 2a Study to Evaluate the Effectiveness and Safety of RXI-109 on the Outcome of Keloid Excision Surgery in Healthy Adults
Status: Enrolling
Updated:  6/13/2016
Clinical Research Facility
mi
from
Miami, FL
A Study to Evaluate the Effectiveness and Safety of RXI-109 on the Outcome of Keloid Excision Surgery in Healthy Adults
A Multi-Center, Prospective, Randomized, Single-Blind, Within-Subject Controlled, Phase 2a Study to Evaluate the Effectiveness and Safety of RXI-109 on the Outcome of Keloid Excision Surgery in Healthy Adults
Status: Enrolling
Updated: 6/13/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate the Effectiveness and Safety of RXI-109 on the Outcome of Keloid Excision Surgery in Healthy Adults
A Multi-Center, Prospective, Randomized, Single-Blind, Within-Subject Controlled, Phase 2a Study to Evaluate the Effectiveness and Safety of RXI-109 on the Outcome of Keloid Excision Surgery in Healthy Adults
Status: Enrolling
Updated:  6/13/2016
Clinical Research Facility
mi
from
St. Louis, MO
A Study to Evaluate the Effectiveness and Safety of RXI-109 on the Outcome of Keloid Excision Surgery in Healthy Adults
A Multi-Center, Prospective, Randomized, Single-Blind, Within-Subject Controlled, Phase 2a Study to Evaluate the Effectiveness and Safety of RXI-109 on the Outcome of Keloid Excision Surgery in Healthy Adults
Status: Enrolling
Updated: 6/13/2016
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Study to Evaluate the Effectiveness and Safety of RXI-109 on the Outcome of Keloid Excision Surgery in Healthy Adults
A Multi-Center, Prospective, Randomized, Single-Blind, Within-Subject Controlled, Phase 2a Study to Evaluate the Effectiveness and Safety of RXI-109 on the Outcome of Keloid Excision Surgery in Healthy Adults
Status: Enrolling
Updated:  6/13/2016
mi
from
San Cristobal,
A Study to Evaluate the Effectiveness and Safety of RXI-109 on the Outcome of Keloid Excision Surgery in Healthy Adults
A Multi-Center, Prospective, Randomized, Single-Blind, Within-Subject Controlled, Phase 2a Study to Evaluate the Effectiveness and Safety of RXI-109 on the Outcome of Keloid Excision Surgery in Healthy Adults
Status: Enrolling
Updated: 6/13/2016
mi
from
San Cristobal,
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia
A Phase 2, Multicenter, Randomized, Double-Blind, Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Solution 5%, Minoxidil Solution 5%, and Vehicle Solution, Applied Twice-daily for 26 Weeks in Males With Androgenetic Alopecia (AGA)
Status: Enrolling
Updated:  6/15/2016
Therapeutics Clinical Research
mi
from
San Diego, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia
A Phase 2, Multicenter, Randomized, Double-Blind, Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Solution 5%, Minoxidil Solution 5%, and Vehicle Solution, Applied Twice-daily for 26 Weeks in Males With Androgenetic Alopecia (AGA)
Status: Enrolling
Updated: 6/15/2016
Therapeutics Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia
A Phase 2, Multicenter, Randomized, Double-Blind, Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Solution 5%, Minoxidil Solution 5%, and Vehicle Solution, Applied Twice-daily for 26 Weeks in Males With Androgenetic Alopecia (AGA)
Status: Enrolling
Updated:  6/15/2016
Minnesota Clinical Study Center
mi
from
Fridley, MN
A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia
A Phase 2, Multicenter, Randomized, Double-Blind, Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Solution 5%, Minoxidil Solution 5%, and Vehicle Solution, Applied Twice-daily for 26 Weeks in Males With Androgenetic Alopecia (AGA)
Status: Enrolling
Updated: 6/15/2016
Minnesota Clinical Study Center
mi
from
Fridley, MN
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia
A Phase 2, Multicenter, Randomized, Double-Blind, Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Solution 5%, Minoxidil Solution 5%, and Vehicle Solution, Applied Twice-daily for 26 Weeks in Males With Androgenetic Alopecia (AGA)
Status: Enrolling
Updated:  6/15/2016
DermResearch, Inc.
mi
from
Austin, TX
A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia
A Phase 2, Multicenter, Randomized, Double-Blind, Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Solution 5%, Minoxidil Solution 5%, and Vehicle Solution, Applied Twice-daily for 26 Weeks in Males With Androgenetic Alopecia (AGA)
Status: Enrolling
Updated: 6/15/2016
DermResearch, Inc.
mi
from
Austin, TX
Click here to add this to my saved trials
Human Phototoxicity Test
Human Phototoxicity Test
Status: Enrolling
Updated:  6/16/2016
Clinical Research Facility
mi
from
Piscataway, NJ
Human Phototoxicity Test
Human Phototoxicity Test
Status: Enrolling
Updated: 6/16/2016
Clinical Research Facility
mi
from
Piscataway, NJ
Click here to add this to my saved trials
Treatment of Androgenetic Alopecia in Males and Females
The Growth of Human Scalp Hair Mediated By Visible Red Light Laser and LED Sources.
Status: Enrolling
Updated:  7/11/2016
Adolfo Fernandez-Obregon
mi
from
Hoboken, NJ
Treatment of Androgenetic Alopecia in Males and Females
The Growth of Human Scalp Hair Mediated By Visible Red Light Laser and LED Sources.
Status: Enrolling
Updated: 7/11/2016
Adolfo Fernandez-Obregon
mi
from
Hoboken, NJ
Click here to add this to my saved trials
Treatment of Androgenetic Alopecia in Males and Females
The Growth of Human Scalp Hair Mediated By Visible Red Light Laser and LED Sources.
Status: Enrolling
Updated:  7/11/2016
Peter S. Halperin, MD
mi
from
New York, NY
Treatment of Androgenetic Alopecia in Males and Females
The Growth of Human Scalp Hair Mediated By Visible Red Light Laser and LED Sources.
Status: Enrolling
Updated: 7/11/2016
Peter S. Halperin, MD
mi
from
New York, NY
Click here to add this to my saved trials
Treatment of Androgenetic Alopecia in Males and Females
The Growth of Human Scalp Hair Mediated By Visible Red Light Laser and LED Sources.
Status: Enrolling
Updated:  7/11/2016
Raymond J. Lanzafame, MD
mi
from
Rochester, NY
Treatment of Androgenetic Alopecia in Males and Females
The Growth of Human Scalp Hair Mediated By Visible Red Light Laser and LED Sources.
Status: Enrolling
Updated: 7/11/2016
Raymond J. Lanzafame, MD
mi
from
Rochester, NY
Click here to add this to my saved trials
Treatment of Androgenetic Alopecia in Males and Females
The Growth of Human Scalp Hair Mediated By Visible Red Light Laser and LED Sources.
Status: Enrolling
Updated:  7/11/2016
Jeffrey A. Sklar, MD
mi
from
Woodbury, NY
Treatment of Androgenetic Alopecia in Males and Females
The Growth of Human Scalp Hair Mediated By Visible Red Light Laser and LED Sources.
Status: Enrolling
Updated: 7/11/2016
Jeffrey A. Sklar, MD
mi
from
Woodbury, NY
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Dunedin, FL
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Dunedin, FL
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Orange Park, FL
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Orange Park, FL
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Newnan, GA
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Newnan, GA
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Grand Blanc, MI
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Grand Blanc, MI
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Verona, NJ
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Verona, NJ
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Gahanna, OH
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Gahanna, OH
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Norfolk, VA
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Birmingham, AL
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Bakersfield, CA
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Mather, CA
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Mather, CA
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Colorado Springs, CO
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Farmington, CT
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Farmington, CT
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Coral Gables, FL
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Jacksonville, FL
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Tampa, FL
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Macon, GA
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Macon, GA
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Champaign, IL
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Champaign, IL
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Chicago, IL
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Boston, MA
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Fort Gratiot, MI
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Fort Gratiot, MI
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Troy, MI
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Troy, MI
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Omaha, NE
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Henderson, NV
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Henderson, NV
Click here to add this to my saved trials
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated:  7/21/2016
Clinical Research Facility
mi
from
Bronx, NY
Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa
A Phase 3, Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa - PIONEER (Open-Label Extension)
Status: Enrolling
Updated: 7/21/2016
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials